Technical Analysis for NSB - NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 0.048 | -7.69% | -0.004 |
NSB closed down 7.69 percent on Friday, April 26, 2024, on 43 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Flat | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 50 DMA | Bearish | 0.00% | |
1,2,3 Pullback Bullish | Bullish Swing Setup | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Narrow Range Bar | Range Contraction | -7.69% | |
Outside Day | Range Expansion | -7.69% | |
Wide Bands | Range Expansion | -7.69% | |
Oversold Stochastic | Weakness | -7.69% | |
Boomer Buy Setup | Bullish Swing Setup | -7.69% | |
Narrow Range Bar | Range Contraction | -7.69% |
Alert | Time |
---|---|
Fell Below 50 DMA | about 18 hours ago |
50 DMA Support | about 21 hours ago |
Down 5% | about 21 hours ago |
1.5x Volume Pace | about 21 hours ago |
Fell Below Previous Day's Low | about 21 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
NeuroScientific Biopharmaceuticals Ltd is an Australia-based pharmaceutical company. The Company develops peptide-based drugs that target neurodegenerative conditions. The Company’s product portfolio consists of EmtinB, 15mS.A, and other Emtin peptides. EmtinB is the Company’s lead therapeutic peptide candidate targeting Alzheimer's disease. 15mS.A. is a diagnostic peptide foe early-stage Alzheimer’s disease. Other Emtin peptides include EmtinAc, EmtinAn, and EmtinBn that demonstrates similar therapeutic properties as EmtinB.
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Disease Drugs Pharmaceuticals Biopharmaceutical Neuroscience Peptide Peptides Alzheimer's Disease Neurodegeneration
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Disease Drugs Pharmaceuticals Biopharmaceutical Neuroscience Peptide Peptides Alzheimer's Disease Neurodegeneration
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 0.14 |
52 Week Low | 0.035 |
Average Volume | 874,426 |
200-Day Moving Average | 0.068 |
50-Day Moving Average | 0.048 |
20-Day Moving Average | 0.057 |
10-Day Moving Average | 0.056 |
Average True Range | 0.005 |
RSI (14) | 44.44 |
ADX | 31.51 |
+DI | 30.048 |
-DI | 27.981 |
Chandelier Exit (Long, 3 ATRs) | 0.065 |
Chandelier Exit (Short, 3 ATRs) | 0.056 |
Upper Bollinger Bands | 0.070 |
Lower Bollinger Band | 0.044 |
Percent B (%b) | 0.15 |
BandWidth | 45.534 |
MACD Line | 0.001 |
MACD Signal Line | 0.003 |
MACD Histogram | -0.0019 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.053 | ||||
Resistance 3 (R3) | 0.053 | 0.052 | 0.052 | ||
Resistance 2 (R2) | 0.052 | 0.051 | 0.052 | 0.051 | |
Resistance 1 (R1) | 0.050 | 0.050 | 0.050 | 0.050 | 0.051 |
Pivot Point | 0.049 | 0.049 | 0.049 | 0.049 | 0.049 |
Support 1 (S1) | 0.047 | 0.048 | 0.047 | 0.047 | 0.045 |
Support 2 (S2) | 0.046 | 0.047 | 0.046 | 0.045 | |
Support 3 (S3) | 0.044 | 0.046 | 0.044 | ||
Support 4 (S4) | 0.044 |